Heron therapeutics, inc. /de/ (HRTX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Net product sales

146,000

77,500

30,767

1,279

0

0

-

-

-

-

-

Contract revenue

-

-

-

-

-

-

-

-

646

1,301

1,261

Cost of product sales

61,619

27,512

4,588

35

0

0

-

-

-

-

-

Research and development

167,382

140,032

138,582

103,125

61,183

54,833

32,516

15,174

8,207

7,264

7,796

General and administrative

37,897

29,263

25,554

21,366

18,395

11,020

21,941

8,657

3,501

3,971

3,707

Sales and marketing

89,764

64,604

56,601

47,668

17,347

8,708

-

-

-

-

-

Total operating expenses

356,662

261,411

225,325

172,194

96,925

74,561

54,457

23,831

11,708

11,235

11,503

Loss from operations

-210,694

-183,937

-194,558

-170,915

-96,925

-74,561

-54,457

-23,831

-11,062

-9,934

-10,242

Other income (expense), net:
Interest income

7,259

5,965

1,049

445

174

-

-

-

-

-

-

Interest expense

1,472

2,672

3,937

2,664

958

887

828

605

-373

-2

29

Gain on sale of royalty interest

-

-

-

-

-

-

-

-

-

2,500

0

Other income, net

158

1,804

-38

-9

118

-919

2

6

-

240

5

Total other income (expense), net

5,945

5,097

-2,926

-2,228

-666

-1,806

-826

-599

-

2,738

24

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-122

Loss from continuing operations

-

-

-

-

-

-

-

-24,430

-11,435

-7,196

-10,096

Gain from discontinued operations

-

-

-

-

-

-

-

1,082

-379

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-10,218

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-150

68

Net loss

-204,749

-178,840

-197,484

-173,143

-97,591

-76,367

-55,283

-23,348

-11,814

-7,346

-10,028

Other comprehensive income:
Unrealized gains on short-term investments

172

-77

7

23

-40

0

0

-

-

-

-

Comprehensive loss

-204,577

-178,917

-197,477

-173,120

-97,631

-76,367

-55,283

-

-

-

-

Loss from continuing operations (in Dollars per share)

-

-

-

-

-

-

-

-2.00

-1.90

-0.18

-0.31

Basic and diluted net loss per share

-2.50

-2.44

-3.65

-4.56

-2.95

-2.87

-3.42

-1.91

-1.96

-0.19

-0.31

Shares used in computing basic and diluted net loss per share

81,779

73,193

54,040

37,925

33,081

26,569

16,163

12,223

6,013

-

-

Weighted-average common shares used to compute basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

39,671

32